62496-43-9Relevant articles and documents
INHIBITORS OF CD40-CD154 BINDING
-
, (2020/10/21)
Disclosed herein are compounds including pharmaceutically acceptable salts, esters, prodrugs, hydrates and tautomers thereof which modulate the interactions of CD-40-CD40L. The compounds are useful for treating, ameliorating or preventing an autoimmune disease, inflammatory disease, or other immune-related disease in a patient in need of treatment.
2,2-Dimethyl-4,5-dimethylen-1,3-cyclopentandiyl
Roth, Wolfgang R.,Kowalczik, Udo,Maier, Guenther,Reisenauer, Hans Peter,Sustmann, Reiner,Mueller, Wolfgang
, p. 1330 - 1331 (2007/10/02)
-